Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0009-0280-03 · Methylprednisolone Acetate Injection · Pfizer Inc.
What is the package ndc for 0009-0280-03 · Methylprednisolone Acetate Injection · Pfizer Inc.?
For 0009-0280-03 · Methylprednisolone Acetate Injection · Pfizer Inc., package ndc is 0009-0280-03; generic name is Methylprednisolone Acetate Injection; manufacturer is Pfizer Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.
"initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0009-0280-03 verified
- Generic name
- Methylprednisolone Acetate Injection verified
- Manufacturer
- Pfizer Inc. verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay verified
- Initial posting date
- 12/15/2021 verified
- Last update date
- 08/24/2026 verified
- Days in shortage
- 1721 our reading
- Reason for shortage
- Other verified
- Dosage form
- Injection verified
- Therapeutic category
- Rheumatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/24/2026", "therapeutic_category": [ "Rheumatology" ], "dosage_form": "Injection", "presentation": "Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)", "company_name": "Pfizer Inc.", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-09-10
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000